|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocm63665050 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
060208s2006 dcuad ob 100 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d OCLCQ
|d NTE
|d IDEBK
|d OCLCQ
|d TUU
|d SNM
|d OCLCQ
|d WVH
|d OCLCQ
|d VAM
|d CUY
|d ADU
|d E7B
|d COCUF
|d DKDLA
|d OCLCE
|d FVL
|d OCLCQ
|d ORU
|d OCLCQ
|d OCLCF
|d NLGGC
|d OCLCQ
|d COO
|d OCL
|d EUW
|d EBLCP
|d OCLCQ
|d AZK
|d LOA
|d OCLCO
|d OCLCA
|d VT2
|d OCLCQ
|d TOA
|d OCLCO
|d AGLDB
|d MOR
|d LIP
|d PIFBR
|d ZCU
|d OCLCO
|d OCLCQ
|d MERUC
|d OCLCO
|d OCLCQ
|d HTC
|d OCLCQ
|d NJR
|d OCLCO
|d WY@
|d OCLCA
|d U3W
|d BUF
|d OCLCO
|d OCLCQ
|d LUE
|d OCLCO
|d KIJ
|d OCLCO
|d OCLCA
|d STF
|d GILDS
|d WRM
|d VNS
|d OCLCQ
|d VTS
|d NRAMU
|d EZ9
|d ICG
|d OCLCO
|d AU@
|d OCLCQ
|d OCLCO
|d WYU
|d OCLCO
|d DKC
|d LVT
|d OCLCQ
|d OCLCO
|d UX1
|d CEF
|d HS0
|d OCLCQ
|d OCLCO
|d UWK
|d OCL
|d UKBTH
|d OCLCQ
|d UKAHL
|d K6U
|d OCLCA
|d UKCRE
|d OCLCO
|d OCLCQ
|d OCLCO
|d ANO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 62872898
|a 133167287
|a 473723664
|a 475327234
|a 607791090
|a 607791091
|a 614851536
|a 636729755
|a 636729772
|a 647464776
|a 722429868
|a 728034186
|a 744956766
|a 814331008
|a 888767939
|a 961584119
|a 962656670
|a 965973129
|a 971084927
|a 975689838
|a 987695420
|a 988452022
|a 990753947
|a 991965673
|a 992069639
|a 1011785412
|a 1013782313
|a 1017610076
|a 1018086057
|a 1021256561
|a 1022027255
|a 1027347600
|a 1028793126
|a 1037942707
|a 1038653100
|a 1041804409
|a 1045374171
|a 1047573736
|a 1048087919
|a 1048168404
|a 1048752732
|a 1055312377
|a 1063983743
|a 1076712999
|a 1081271975
|a 1084334316
|a 1101716325
|a 1103548546
|a 1108958175
|a 1110285328
|a 1112435183
|a 1112795846
|a 1113095574
|a 1119038981
|a 1119436761
|a 1119516622
|a 1120027856
|a 1120893972
|a 1124482925
|a 1125453797
|a 1136185673
|a 1142747633
|a 1153476409
|a 1156344078
|a 1159633131
|a 1182011578
|a 1193123129
|a 1204376974
|a 1204393797
|a 1227634904
|a 1228603436
|a 1229441862
|a 1249216802
|
020 |
|
|
|a 0309654904
|q (electronic bk.)
|
020 |
|
|
|a 9780309654906
|q (electronic bk.)
|
020 |
|
|
|a 1280310057
|
020 |
|
|
|a 9781280310058
|
020 |
|
|
|a 9786610310050
|
020 |
|
|
|a 661031005X
|
020 |
|
|
|z 0309100569
|q (pbk.)
|
020 |
|
|
|z 9780309100564
|q (pbk.)
|
029 |
1 |
|
|a AU@
|b 000044593349
|
029 |
1 |
|
|a AU@
|b 000050984447
|
029 |
1 |
|
|a AU@
|b 000051533430
|
029 |
1 |
|
|a AU@
|b 000053246869
|
029 |
1 |
|
|a DEBBG
|b BV043097489
|
029 |
1 |
|
|a DEBBG
|b BV044108486
|
029 |
1 |
|
|a DEBSZ
|b 422286702
|
029 |
1 |
|
|a GBVCP
|b 801393507
|
029 |
1 |
|
|a NZ1
|b 12033746
|
035 |
|
|
|a (OCoLC)63665050
|z (OCoLC)62872898
|z (OCoLC)133167287
|z (OCoLC)473723664
|z (OCoLC)475327234
|z (OCoLC)607791090
|z (OCoLC)607791091
|z (OCoLC)614851536
|z (OCoLC)636729755
|z (OCoLC)636729772
|z (OCoLC)647464776
|z (OCoLC)722429868
|z (OCoLC)728034186
|z (OCoLC)744956766
|z (OCoLC)814331008
|z (OCoLC)888767939
|z (OCoLC)961584119
|z (OCoLC)962656670
|z (OCoLC)965973129
|z (OCoLC)971084927
|z (OCoLC)975689838
|z (OCoLC)987695420
|z (OCoLC)988452022
|z (OCoLC)990753947
|z (OCoLC)991965673
|z (OCoLC)992069639
|z (OCoLC)1011785412
|z (OCoLC)1013782313
|z (OCoLC)1017610076
|z (OCoLC)1018086057
|z (OCoLC)1021256561
|z (OCoLC)1022027255
|z (OCoLC)1027347600
|z (OCoLC)1028793126
|z (OCoLC)1037942707
|z (OCoLC)1038653100
|z (OCoLC)1041804409
|z (OCoLC)1045374171
|z (OCoLC)1047573736
|z (OCoLC)1048087919
|z (OCoLC)1048168404
|z (OCoLC)1048752732
|z (OCoLC)1055312377
|z (OCoLC)1063983743
|z (OCoLC)1076712999
|z (OCoLC)1081271975
|z (OCoLC)1084334316
|z (OCoLC)1101716325
|z (OCoLC)1103548546
|z (OCoLC)1108958175
|z (OCoLC)1110285328
|z (OCoLC)1112435183
|z (OCoLC)1112795846
|z (OCoLC)1113095574
|z (OCoLC)1119038981
|z (OCoLC)1119436761
|z (OCoLC)1119516622
|z (OCoLC)1120027856
|z (OCoLC)1120893972
|z (OCoLC)1124482925
|z (OCoLC)1125453797
|z (OCoLC)1136185673
|z (OCoLC)1142747633
|z (OCoLC)1153476409
|z (OCoLC)1156344078
|z (OCoLC)1159633131
|z (OCoLC)1182011578
|z (OCoLC)1193123129
|z (OCoLC)1204376974
|z (OCoLC)1204393797
|z (OCoLC)1227634904
|z (OCoLC)1228603436
|z (OCoLC)1229441862
|z (OCoLC)1249216802
|
037 |
|
|
|n Title subscribed to via ProQuest Academic Complete
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RM265.2
|b .N38 2006eb
|
060 |
|
4 |
|a QV 250
|b N277t 2006
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.329
|2 22
|
049 |
|
|
|a UAMI
|
110 |
2 |
|
|a National Research Council (U.S.).
|b Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials.
|
245 |
1 |
0 |
|a Treating infectious diseases in a microbial world :
|b report of two workshops on novel antimicrobial therapeutics /
|c Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials ; Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies.
|
260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c ©2006.
|
300 |
|
|
|a 1 online resource (x, 92 pages) :
|b illustrations, charts
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|2 rdaft
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a Challenges for the Development of New Antimicrobials: Rethinking the Approaches: Report of a Workshop -- Promising Approaches to the Development of Immunomodulation for the Treatment of Infectious Diseases: Report of a Workshop.
|
520 |
|
|
|a Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic.
|
588 |
0 |
|
|a Print version record.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
546 |
|
|
|a English.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Anti-infective agents
|x Therapeutic use
|v Congresses.
|
650 |
|
0 |
|a Communicable diseases
|x Treatment
|v Congresses.
|
650 |
|
0 |
|a Infection
|x Treatment
|v Congresses.
|
650 |
|
0 |
|a Anti-infective agents.
|
650 |
|
0 |
|a Bacterial diseases.
|
650 |
|
0 |
|a Infection.
|
650 |
|
0 |
|a Diseases.
|
650 |
|
2 |
|a Communicable Diseases
|x drug therapy
|
650 |
|
2 |
|a Immunologic Factors
|x therapeutic use
|
650 |
|
2 |
|a Immune System
|x physiopathology
|
650 |
|
2 |
|a Anti-Infective Agents
|
650 |
|
2 |
|a Anti-Infective Agents
|x therapeutic use
|
650 |
|
2 |
|a Bacterial Infections
|
650 |
|
2 |
|a Infections
|
650 |
|
2 |
|a Bacterial Infections and Mycoses
|
650 |
|
2 |
|a Therapeutic Uses
|
650 |
|
2 |
|a Disease
|
650 |
|
2 |
|a Pharmacologic Actions
|
650 |
|
2 |
|a Chemical Actions and Uses
|
650 |
|
2 |
|a Chemicals and Drugs
|
650 |
|
2 |
|a Anti-Bacterial Agents
|x therapeutic use
|
650 |
|
6 |
|a Antiinfectieux
|x Emploi en thérapeutique
|v Congrès.
|
650 |
|
6 |
|a Maladies infectieuses
|x Traitement
|v Congrès.
|
650 |
|
6 |
|a Infection
|x Traitement
|v Congrès.
|
650 |
|
6 |
|a Antiinfectieux.
|
650 |
|
6 |
|a Maladies bactériennes.
|
650 |
|
6 |
|a Infection.
|
650 |
|
6 |
|a Maladies.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Infection
|2 fast
|
650 |
|
7 |
|a Diseases
|2 fast
|
650 |
|
7 |
|a Bacterial diseases
|2 fast
|
650 |
|
7 |
|a Anti-infective agents
|2 fast
|
650 |
|
7 |
|a Anti-infective agents
|x Therapeutic use
|2 fast
|
650 |
|
7 |
|a Communicable diseases
|x Treatment
|2 fast
|
650 |
|
7 |
|a Infection
|x Treatment
|2 fast
|
655 |
|
2 |
|a Congress
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congrès.
|2 rvmgf
|
710 |
2 |
|
|a National Research Council (U.S.).
|b Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation.
|
776 |
0 |
8 |
|i Print version:
|a National Research Council (U.S.). Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials.
|t Treating infectious diseases in a microbial world.
|d Washington, DC : National Academies Press, ©2006
|z 0309100569
|w (OCoLC)63271499
|
830 |
|
0 |
|a Online access: NCBI NCBI Bookshelf.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378039
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36567650
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3378039
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10110304
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 148934
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 31005
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2394543
|
994 |
|
|
|a 92
|b IZTAP
|